Cargando…

Trends and Outcome from Radical Therapy for Primary Non-Metastatic Prostate Cancer in a UK Population

BACKGROUND: Increasing proportions of men diagnosed with prostate cancer in the UK are presenting with non-metastatic disease. We investigated how treatment trends in this demographic have changed. PATIENT AND METHODS: Non-metastatic cancers diagnosed from 2000–2010 in the UK Anglian Cancer network...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greenberg, David C., Lophatananon, Artitaya, Wright, Karen A., Muir, Kenneth R., Gnanapragasam, Vincent J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351083/ https://www.ncbi.nlm.nih.gov/pubmed/25742020 http://dx.doi.org/10.1371/journal.pone.0119494

Ejemplares similares

Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study
por: Gnanapragasam, Vincent J., et al.
Publicado: (2016)

Changing presentation of prostate cancer in a UK population – 10 year trends in prostate cancer risk profiles in the East of England
por: Greenberg, D C, et al.
Publicado: (2013)

Prediction models for prostate cancer to be used in the primary care setting: a systematic review
por: Aladwani, Mohammad, et al.
Publicado: (2020)

Risk Factors Associated with Pancreatic Cancer in the UK Biobank Cohort
por: Ke, Te-Min, et al.
Publicado: (2022)

Assessing the impact of MRI based diagnostics on pre-treatment disease classification and prognostic model performance in men diagnosed with new prostate cancer from an unscreened population
por: Lophatananon, Artitaya, et al.
Publicado: (2022)

Association between an inflammatory biomarker score and future dementia diagnosis in the population-based UK Biobank cohort of 500,000 people
por: Mekli, Krisztina, et al.
Publicado: (2023)

Risk of breast cancer in the UK biobank female cohort and its relationship to anthropometric and reproductive factors
por: Al-Ajmi, Kawthar, et al.
Publicado: (2018)

Investigation of the association between the antibody responses to neurotropic viruses and dementia outcomes in the UK Biobank
por: Mekli, Krisztina, et al.
Publicado: (2022)

The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study
por: Gnanapragasam, V. J., et al.
Publicado: (2018)

Association of Nongenetic Factors With Breast Cancer Risk in Genetically Predisposed Groups of Women in the UK Biobank Cohort
por: Al Ajmi, Kawthar, et al.
Publicado: (2020)

Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: continuous survey
por: Lyratzopoulos, Georgios, et al.
Publicado: (2010)

Shingles, Zostavax vaccination and risk of developing dementia: a nested case–control study—results from the UK Biobank cohort
por: Lophatananon, Artitaya, et al.
Publicado: (2021)

The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink
por: Lophatananon, Artitaya, et al.
Publicado: (2023)

Incorporating multiparametric MRI staging and the new histological Grade Group system improves risk-stratified detection of bone metastasis in prostate cancer
por: Thurtle, David, et al.
Publicado: (2016)

Exploring the causal role of the immune response to varicella-zoster virus on multiple traits: a phenome-wide Mendelian randomization study
por: Yu, Xinzhu, et al.
Publicado: (2023)

Re-evaluating the diagnostic efficacy of PSA as a referral test to detect clinically significant prostate cancer in contemporary MRI-based image-guided biopsy pathways
por: Lophatananon, Artitaya, et al.
Publicado: (2023)

Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study
por: Aladwani, Mohammad, et al.
Publicado: (2020)

Review of non-clinical risk models to aid prevention of breast cancer
por: Al-Ajmi, Kawthar, et al.
Publicado: (2018)

Urinary symptoms and prostate cancer—the misconception that may be preventing earlier presentation and better survival outcomes
por: Gnanapragasam, Vincent J., et al.
Publicado: (2022)

Risk profiles of prostate cancers identified from UK primary care using national referral guidelines
por: Serag, H, et al.
Publicado: (2012)

Development and External Validation of the STRATified CANcer Surveillance (STRATCANS) Multivariable Model for Predicting Progression in Men with Newly Diagnosed Prostate Cancer Starting Active Surveillance
por: Light, Alexander, et al.
Publicado: (2022)

Responses to provision of personalised cancer risk information: a qualitative interview study with members of the public
por: Usher-Smith, Juliet A., et al.
Publicado: (2017)

Common genetic and clinical risk factors: Association with fatal prostate cancer in the Cohort of Swedish Men
por: Huynh-Le, Minh-Phuong, et al.
Publicado: (2021)

Clinical characteristics and outcomes for patients with non‑metastatic castration-resistant prostate cancer
por: Arnold, Peter, et al.
Publicado: (2021)

Models predicting survival to guide treatment decision-making in newly diagnosed primary non-metastatic prostate cancer: a systematic review
por: Thurtle, David, et al.
Publicado: (2019)

Evaluation of a questionnaire to assess nutritional knowledge, attitudes and practices in a Thai population
por: Pongkiatchai, Rungnapa, et al.
Publicado: (2019)

Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement
por: Merriel, Samuel W.D., et al.
Publicado: (2019)

Understanding of prognosis in non-metastatic prostate cancer: a randomised comparative study of clinician estimates measured against the PREDICT prostate prognostic model
por: Thurtle, David R., et al.
Publicado: (2019)

CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer
por: Nyberg, Tommy, et al.
Publicado: (2023)

Online Decision Support Tool for Personalized Cancer Symptom Checking in the Community (REACT): Acceptability, Feasibility, and Usability Study
por: Nieroda, Marzena Ewa, et al.
Publicado: (2018)

Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)
por: Thurtle, David, et al.
Publicado: (2020)

Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer
por: Babst, Christa, et al.
Publicado: (2022)

Outcome of radical prostatectomy in primary circulating prostate cell negative prostate cancer
por: Murray, Nigel P, et al.
Publicado: (2016)

Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model
por: Thurtle, David R., et al.
Publicado: (2019)

Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No
por: Ristau, Benjamin T., et al.
Publicado: (2016)

Characteristics and national trends of patients receiving treatment of the primary tumor for metastatic prostate cancer()
por: Sinha, Sumi, et al.
Publicado: (2017)

Trends in Incidence of Metastatic Prostate Cancer in the US
por: Desai, Mihir M., et al.
Publicado: (2022)

Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures
por: Wadhwa, Karan, et al.
Publicado: (2017)

Outcomes of laparoscopic salvage radical prostatectomy after primary treatment of prostate cancer
por: Catarino, Raquel, et al.
Publicado: (2022)

Clinical outcome in metastatic prostate cancer after primary radiotherapy
por: Moll, Matthias, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bk79ml0pgqc8hpmbvcg46jb6vo